logo
RFK Jr.'s latest big move could leave you paying more for vaccines

RFK Jr.'s latest big move could leave you paying more for vaccines

Yahoo12-06-2025
Health Secretary Robert F. Kennedy Jr. sent shockwaves through the scientific community this week when he fired all 17 members of the federal government's key vaccine advisory board, raising concerns that he might try to replace them with immunization skeptics.
Those fears were confirmed for many on Wednesday when Kennedy unveiled eight new members who included some of the most prominent critics of the COVID-19 vaccines.
The swap could have wide-reaching public health consequences. But one of the most straightforward impacts may be on consumers' wallets.
That's because recommendations by the board — known as the Advisory Committee for Immunization Practices, or ACIP — determine which vaccines most insurance plans are required to cover at zero cost, such as inoculation against measles or your annual flu shot. If the new members decide to reverse the panel's old guidance, patients could find themselves paying out of pocket for vaccines that were once available for free.
'For the average person who has never heard of ACIP before, this could affect their access to vaccines,' said Jennifer Kates, a senior vice president at the healthcare think tank KFF.
Created in 1964, ACIP is the official outside panel of medical experts responsible for advising the Centers for Disease Control and Prevention (CDC) on what to include on its lists of routine shots for both children and adults. While its recommendations aren't binding, federal officials have typically adopted them.
As a result, the board's decisions carry enormous weight, affecting patients and parents, as well as the vaccines schools require for students. Over the years, the panel has played a growing role in determining insurance coverage as well.
By law, shots recommended by ACIP must be covered by the free Vaccines for Children program, the Children's Health Insurance Program, Medicaid, and Medicare Part D. The Affordable Care Act also requires private insurers to pay for vaccines with no cost sharing if they have the panel's seal of approval. (Past administrations have said the rule only applies if the CDC also adopts the board's recommendation.)
In a Wall Street Journal op-ed this week, Kennedy said his decision to replace the board was meant to fight a 'crisis of public trust' in vaccines by ridding the committee of what he described as 'persistent conflicts of interest.' (Kennedy's critics have argued that his allegations against ACIP's former members are unfounded.)
His new picks for the panel include several figures who rose to national fame by casting doubt on the safety of COVID-19 vaccines. Among them is Dr. Robert Malone, an accomplished scientist who did pioneering work on mRNA technology but later attacked its use in shots during the pandemic and who was at one point banned from Twitter for spreading COVID misinformation.
He'll be joined by Retsef Levi, an MIT business school professor who gained attention in 2023 for claiming there was 'indisputable evidence' ​​that 'MRNA vaccines cause serious harm including death,' and Dr. Martin Kulldorff, who advocated letting COVID spread among younger Americans to achieve 'herd immunity' and was later let go from Harvard Medical after refusing to be vaccinated.
In his announcement, Kennedy said that each new member of ACIP was 'committed to demanding definitive safety and efficacy data before making any new vaccine recommendations' — suggesting they'll be less likely to add new shots to the government's immunization schedules.
But he added that the board will also 'review safety and efficacy data for the current schedule as well,' raising the possibility that it will scrap some of its old recommendations.
Even before this week's shake-up, the government had already begun changing its recommendations on COVID shots. In May, the CDC dropped its recommendation that healthy pregnant women receive the vaccine and revised its guidance for young children, saying they should only receive it after consultation with a doctor.
Private insurers could still choose to cover vaccines even if the federal government stops recommending them. Whether they will is less certain. 'That's territory we haven't really had to traverse before,' said KFF's Kates.
Sarah Moselle, a vaccine market expert at the health industry consulting firm Avalere, said there may be some 'fragmentation' in how carriers approach the issue. Some may drop coverage entirely or begin requiring co-pays. But many 'do anticipate that they would continue to cover some vaccines,' even if they aren't required to, since it would 'add value' for their customers, she said.
In theory, insurers could also have an incentive to maintain vaccine coverage since it could keep their patients healthier and reduce the costs of their care, though it's unclear exactly how those savings would stack up against the added expense of paying for shots.
For many vaccines, the out-of-pocket cost might be relatively cheap for patients. But others could turn out to be steep.
Take Gardasil, the HPV vaccine that has been the focus of growing safety concerns among patients despite studies suggesting they're unfounded. Some experts told Yahoo Finance they thought the shot could be a target for more scrutiny under Kennedy's new ACIP. Currently, the shot is covered by insurance because it's recommended for pre-teens through young adults. The CDC lists its full price at over $300 a dose.
Even modest costs can dissuade patients from getting vaccinated, according to Loren Adler, associate director at the Brookings Institution's Center on Health Policy. 'We know that folks having to pay $10 for a vaccine limits the uptake somewhat,' he said. As a result, just a small increase in what patients have to pay out of pocket could have ripple effects on public health.
One issue to keep an eye on, according to Moselle, is whether state governments step in to require more extensive insurance coverage of vaccines if the federal government walks back some of its recommendations. If they do, vaccine access could start to vary more by where patients happen to live.
Jordan Weissmann is a senior reporter at Yahoo Finance.
Click here for in-depth analysis of the latest health industry news and events impacting stock prices
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Top Scientist Issues Stark mRNA Vaccine Warning to U.S.
Top Scientist Issues Stark mRNA Vaccine Warning to U.S.

Newsweek

time28 minutes ago

  • Newsweek

Top Scientist Issues Stark mRNA Vaccine Warning to U.S.

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Rick Bright, the former director of the Biomedical Advanced Research and Development Authority (BARDA) has warned that Department of Health and Human Services' decision to cut funding for mRNA vaccine development could threaten American national security. "BARDA wasn't the only government agency making early investments in mRNA research," Bright wrote in an opinion piece for The New York Times. "The Department of Defense and the Defense Advanced Research Projects Agency had already recognized mRNA's potential for swift action against emerging biological threats, including those that might be weaponized." It comes after HHS Secretary Robert F. Kennedy Jr. announced the termination of 22 mRNA development investments and the reallocation of roughly $500 million at the beginning of this month. Why it Matters Bright said the mRNA platform had been central to the fast response to COVID-19 and that abandoning the technology would undermine the nation's ability to respond quickly to future biological threats. Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head." What To Know On August 5, the HHS confirmed it would cancel $500 million in mRNA vaccine development contracts, impacting research teams and proposals—including those from Emory University, Tiba Biotech, Pfizer, Sanofi Pasteur and others. The projects reportedly targeted respiratory viruses including seasonal influenza, COVID-19, RSV and H5N1 and included work by major industry and academic teams. Secretary Kennedy argued that the data showed mRNA vaccines had not met expectations for preventing upper respiratory infections and that HHS would shift funding toward other vaccine platforms. But Bright praised mRNA technology, saying that the "unprecedented speed" with which a COVID-19 vaccine was developed in 2020 "was possible only because years earlier, the United States had invested" in it. "This decision undercuts one of the most significant medical advances in decades, technology that could protect millions more people from the threats ahead," Bright said. "I know the stakes because I was BARDA's director when the United States made the decision to invest heavily in mRNA," he said. "That investment did not begin with Covid-19. It began in 2016, when we faced the Zika virus outbreak." "We needed a way to design a vaccine in days, not years, to protect pregnant women and their babies from devastating birth defects. Older vaccine approaches were too slow," Bright continued. "The solution was mRNA: a flexible, rapid-response technology that could be reprogrammed for any virus once its genetic sequence was known. That early investment laid the groundwork for the lightning-fast Covid-19 response four years later." Kennedy said in a post on X the time: "We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," Kennedy said in a post on X. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." Newsweek has contacted the HHS, via online inquiry form, for a response to Bright's comments. File photo of an employee of the Bavarian Red Cross (BRK) preparing the BioNTech/Pfizer vaccine against the coronavirus SARS-CoV-2 for vaccination in a vaccination center, taken in Bavaria, Germany, in January 2021. File photo of an employee of the Bavarian Red Cross (BRK) preparing the BioNTech/Pfizer vaccine against the coronavirus SARS-CoV-2 for vaccination in a vaccination center, taken in Bavaria, Germany, in January 2021. AP What People Are Saying Former BARDA director Rick Bright said in his NYT op-ed: "Like every technology, mRNA has limitations. Vaccines meant to protect against respiratory infections, whether developed through mRNA or older technologies, are generally better at averting severe disease than preventing infection. It is a scientific challenge we can address with next-generation vaccines. The answer to limitations is improvement, not abandonment. "Political narratives about mRNA have fueled confusion, which leads to mistrust, yet the scientific evidence consistently shows that this technology is safe and effective and holds enormous potential for future vaccines and treatments." Children's Health Defense, an anti-vax nonprofit founded by Kennedy Jr. which focuses on childhood health epidemics, said in a post on X: "CHD applauds this most recent announcement to defund 22 mRNA vaccine projects under BARDA. While we believe that the mRNA shots on the market are unsafe and should be off the market, this is a welcome step in the right direction. The pandemic preparedness industry as it exists today is a threat to human welfare." What Happens Next HHS said it would shift funding toward other vaccine platforms but did not provide detailed timelines or specify which programs would receive redirected support. Scientific organizations, industry groups and public-health leaders said they would assess the impact and consider next steps, while some public-health advocates announced initiatives to defend vaccine science and provide public information.

What is carbon monoxide poisoning, and how can you prevent it?
What is carbon monoxide poisoning, and how can you prevent it?

NBC News

time29 minutes ago

  • NBC News

What is carbon monoxide poisoning, and how can you prevent it?

Carbon monoxide (CO) is an odorless, colorless and toxic gas that causes hundreds of unintentional deaths a year, according to the Centers for Disease Control and Prevention (CDC). The gas is invisible to our eyes and CO poisoning symptoms are flu-like, which is why it can sometimes go unnoticed. That's why a carbon monoxide detector is essential for any living space. We collected CO guidance from government agencies like the CDC and U.S. Environmental Protection Agency (EPA), and recommend top-rated CO detectors below. Want more from NBC Select? Sign up for our newsletter, The Selection, and shop smarter. What is carbon monoxide? Carbon monoxide is an odorless, colorless and toxic gas. Common household sources of carbon monoxide include fuel-fired heating and cooking appliances like gas space heaters, gas stoves, gas grills, gas water heaters and improperly vented fireplaces, to name a few. CO can accumulate to dangerous levels when any fuel-fired combustion source is used improperly and not adequately vented to the outdoors, says Carolyn Holran, the press secretary at the EPA. Inhaling CO can cause a variety of symptoms (more on those later), but inhaling a lot of CO can cause you to pass out and may kill you, according to the EPA and CDC. How we picked top-rated carbon monoxide detectors Carbon monoxide detectors tend to look similar to each other and often don't have specific product names, just model numbers like CO615 or C05120BN, which makes buying one even more confusing. We picked CO detectors based on the following criteria: Certifications: All of our picks are certified to UL 2034, a recognized safety standard from Underwriters Laboratories, an independent global safety science company. Power supply: We include carbon monoxide detectors that can be powered by different kinds of sources, including plug-in and battery-powered models. Extra features: We also noted useful extra features like an LED screen and battery backups in our selection. Most of our top picks come from two well-known safety brands: First Alert and Kidde. We selected models with at least a 4.5-star average rating from hundreds of reviews on online storefronts like Amazon. Plug-in CO detectors are convenient because you can place them wherever you have a wall outlet. This model also has a battery backup (powered by two AA batteries), so it will keep running even during a power outage. The LED screen indicates backup battery level as well as CO levels. The brand also makes a lower-priced version without a screen. Travel pick If you are a frequent traveler and often find yourself staying in short-term lodging, consider bringing this portable CO detector with you. In the US, only 14 states require CO detectors in temporary lodging, and a lack of CO detectors has led to hospitalization and deaths locally and abroad. It has a built-in lithium battery with up to 10 years of battery life. Battery-powered pick If you need a CO detector for an area of your home that does not have a wall outlet or hardwire option, consider a battery-powered model like this one from First Alert. It runs off of two AA batteries, included in the box. For hardwiring If you prefer hardwiring your CO detector, this model is a good fit, plus it has a battery backup through a regular 9V alkaline battery. It doesn't have a screen — push and hold the single button to test the alarm, or push it once to silence the low-battery chirp. Frequently asked questions What about CO detectors from Kidde? Kidde and First Alert are two of the biggest brands in the CO detector space. Kidde, however, has a much more extensive history of product recalls with its fire extinguishers, smoke detectors and carbon monoxide detectors than First Alert. In 2021, a federal judge ordered the brand to pay a $12 million civil penalty in connection with allegations that the company 'failed to timely inform the Consumer Product Safety Commission (CPSC) about problems with fire extinguishers manufactured by the company.' First Alert has had recalls too, but not as many as Kidde, and not for as many units. What are symptoms of carbon monoxide poisoning? Carbon monoxide poisoning can seem like flu-like symptoms without a fever, says Holran. Carbon monoxide exposure can cause headaches, dizziness, weakness, nausea, shortness of breath, confusion and fainting. High levels of CO exposure can cause death. How do you prevent carbon monoxide in your home? There are multiple ways to prevent a carbon monoxide incident from occurring in your home. Most prevention methods revolve around fuel-fired appliances and ventilation. Vent fuel-fired, combustion appliances to the outdoors — think stoves, heaters, furnaces and fireplaces. Avoid the use of unvented appliances (or fireplaces) indoors. Run vehicles outside your garage. If you need to warm up a vehicle, start it inside your garage and remove it immediately after starting. Run fuel-powered portable generators outdoors, at least 20 feet away from buildings and structures. If you need a generator for indoor use, consider a battery or solar powered station instead. Test all CO detectors monthly, and replace them according to manufacturer instructions. Have a professional inspect, clean and tune central heating systems like furnaces, flutes and chimneys annually. Meet our expert At NBC Select, we work with experts who have specialized knowledge and authority based on relevant training and/or experience. We also take steps to ensure all expert advice and recommendations are made independently and without undisclosed financial conflicts of interest. Why trust NBC Select? I'm a reporter at NBC Select who covers technology and fitness including recent stories on air purifiers, wireless earbuds, and walking shoes. For this piece, I researched carbon monoxide and pulled information from reputable agencies like the Centers for Disease Control and Prevention (CDC) and Environmental Protection Agency (EPA).

America's first needle-free, at-home flu vaccine is now available
America's first needle-free, at-home flu vaccine is now available

Yahoo

time31 minutes ago

  • Yahoo

America's first needle-free, at-home flu vaccine is now available

There's one less excuse to skip the flu shot this season. Unsold completed new-build inventory is so high this $34B homebuilder is turning to investors 'Job hugging' is the newest career trend: Here's what it means—and why Gen Z is into it Spotify just redesigned the way you'll 'listen' to audiobooks Pharmaceutical company AstraZeneca is out with a new version of the flu vaccine, and it makes getting vaccinated easier than ever. The drug can be administered at home, giving you one less reason to trek to the doctor's office. And even better for the needle-averse: You don't need a jab to get it—the vaccine comes in nasal spray form. The drug, which was approved by the Food and Drug Administration last fall, is available now and can be ordered online. While it will cost $70 out of pocket, AstraZeneca says that anyone with insurance coverage will only need to pay $8.99 for shipping. FluMist Home ships in a special cooling container and needs to be stored in a cool environment. So if you order the vaccine, you'll need to pop it in the fridge until you plan to administer it. Flu vaccination rates are on the downswing in the U.S., a phenomenon linked to pandemic fatigue and vaccine misinformation. While the flu is an endemic virus that comes back around every year, it can still be dangerous for unimmunized kids, older adults, and people with compromised immune systems. The flu vaccine isn't the only shot that Americans are skipping. From 2019 to 2023, measles vaccination rates fell from 95% to 92%, dipping below the critical threshold for population-level protection. Anti-vaccine activism is rising in the U.S., and that movement now has Robert F. Kennedy Jr., a prominent ally, running the Department of Health and Human Services. On Thursday, HHS announced that it will bring back a task force aimed at scrutinizing the safety of vaccines for children. The Children's Health Defense, an anti-vaccine group founded by Kennedy, called for the task force to be reestablished in a lawsuit filed against its former leader in May. This post originally appeared at to get the Fast Company newsletter: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store